BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36031232)

  • 1. Effect of astragaloside IV and salvianolic acid B on antioxidant stress and vascular endothelial protection in the treatment of atherosclerosis based on metabonomics.
    Kong XL; Lyu Q; Zhang YQ; Kang DF; Li C; Zhang L; Gao ZC; Liu XX; Wu JB; Li YL
    Chin J Nat Med; 2022 Aug; 20(8):601-613. PubMed ID: 36031232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astragaloside IV improves the isoproterenol-induced vascular dysfunction via attenuating eNOS uncoupling-mediated oxidative stress and inhibiting ROS-NF-κB pathways.
    Xu C; Tang F; Lu M; Yang J; Han R; Mei M; Hu J; Zhou M; Wang H
    Int Immunopharmacol; 2016 Apr; 33():119-27. PubMed ID: 26903414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Nrf2/HO-1 signaling: An important molecular mechanism of herbal medicine in the treatment of atherosclerosis
    Zhang Q; Liu J; Duan H; Li R; Peng W; Wu C
    J Adv Res; 2021 Dec; 34():43-63. PubMed ID: 35024180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvianolic acid B improves vascular endothelial function in diabetic rats with blood glucose fluctuations via suppression of endothelial cell apoptosis.
    Ren Y; Tao S; Zheng S; Zhao M; Zhu Y; Yang J; Wu Y
    Eur J Pharmacol; 2016 Nov; 791():308-315. PubMed ID: 27614127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of IGF1R signaling in the protective effect of Astragaloside IV on ischemia and reperfusion-induced cardiac microvascular endothelial hyperpermeability.
    He K; Yan L; Lin SQ; Liu YY; Hu BH; Chang X; Zhao XR; He SY; Wei XH; Fan JY; Pan CS; Han JY
    Phytomedicine; 2022 Jun; 100():154045. PubMed ID: 35338991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Protective mechanism of salvianolic acid B on blood vessels].
    Yang CK; Pan QQ; Tian Z; DU YJ; Sun FQ; Lu J; Li J
    Zhongguo Zhong Yao Za Zhi; 2023 Mar; 48(5):1176-1185. PubMed ID: 37005801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvianolic acid B inhibits low-density lipoprotein oxidation and neointimal hyperplasia in endothelium-denuded hypercholesterolaemic rabbits.
    Yang TL; Lin FY; Chen YH; Chiu JJ; Shiao MS; Tsai CS; Lin SJ; Chen YL
    J Sci Food Agric; 2011 Jan; 91(1):134-41. PubMed ID: 20824680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astragaloside IV blocks monocrotaline‑induced pulmonary arterial hypertension by improving inflammation and pulmonary artery remodeling.
    Jin H; Jiao Y; Guo L; Ma Y; Zhao R; Li X; Shen L; Zhou Z; Kim SC; Liu J
    Int J Mol Med; 2021 Feb; 47(2):595-606. PubMed ID: 33416126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
    Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H
    PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astragaloside IV Alleviates Liver Inflammation, Oxidative Stress and Apoptosis to Protect Against Experimental Non-Alcoholic Fatty Liver Disease.
    Liang XY; Hong FF; Yang SL
    Diabetes Metab Syndr Obes; 2021; 14():1871-1883. PubMed ID: 33953586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of astragaloside IV against rat myocardial cell apoptosis induced by oxidative stress via mitochondrial ATP-sensitive potassium channels.
    Guan FY; Yang SJ; Liu J; Yang SR
    Mol Med Rep; 2015 Jul; 12(1):371-6. PubMed ID: 25739067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study on inhibition of total astragalus saponins and astragaloside IV on TNFR1-mediated signaling pathways in arterial endothelial cells.
    Liu QS; Wang HF; Sun AK; Huo XP; Liu JL; Ma SH; Peng N; Hu J
    PLoS One; 2014; 9(7):e101504. PubMed ID: 24991819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astragaloside IV protects blood-brain barrier integrity from LPS-induced disruption via activating Nrf2 antioxidant signaling pathway in mice.
    Li H; Wang P; Huang F; Jin J; Wu H; Zhang B; Wang Z; Shi H; Wu X
    Toxicol Appl Pharmacol; 2018 Feb; 340():58-66. PubMed ID: 29294303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astragaloside IV ameliorates pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension by restraining the T follicular helper cell response and expanding T follicular regulatory cell response.
    Li C; Zhu H; Zhang S; Meng F; Li S; Li G; Zha J; Wu S; Zhu L; Dai A
    Phytomedicine; 2022 Jul; 102():154171. PubMed ID: 35636165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-glycoprotein Inhibitor Tariquidar Potentiates Efficacy of Astragaloside IV in Experimental Autoimmune Encephalomyelitis Mice.
    Zhang W; Liu M; Yang L; Huang F; Lan Y; Li H; Wu H; Zhang B; Shi H; Wu X
    Molecules; 2019 Feb; 24(3):. PubMed ID: 30717494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvianolic acid B attenuates VCAM-1 and ICAM-1 expression in TNF-alpha-treated human aortic endothelial cells.
    Chen YH; Lin SJ; Ku HH; Shiao MS; Lin FY; Chen JW; Chen YL
    J Cell Biochem; 2001; 82(3):512-21. PubMed ID: 11500927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Combined Use of Astragaloside IV (AsIV) and Atorvastatin (AV) on Expression of PPAR-γ and Inflammation-Associated Cytokines in Atherosclerosis Rats.
    Sun B; Rui R; Pan H; Zhang L; Wang X
    Med Sci Monit; 2018 Sep; 24():6229-6236. PubMed ID: 30190450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astragaloside IV ameliorates cisplatin-induced liver injury by modulating ferroptosis-dependent pathways.
    Guo J; Le Y; Yuan A; Liu J; Chen H; Qiu J; Wang C; Dou X; Yuan X; Lu D
    J Ethnopharmacol; 2024 Jun; 328():118080. PubMed ID: 38521426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astragaloside IV prevents high glucose‑induced cell apoptosis and inflammatory reactions through inhibition of the JNK pathway in human umbilical vein endothelial cells.
    You L; Fang Z; Shen G; Wang Q; He Y; Ye S; Wang L; Hu M; Lin Y; Liu M; Jiang A
    Mol Med Rep; 2019 Mar; 19(3):1603-1612. PubMed ID: 30628687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astragaloside IV attenuates apoptosis of hypertrophic cardiomyocyte through inhibiting oxidative stress and calpain-1 activation.
    Mei M; Tang F; Lu M; He X; Wang H; Hou X; Hu J; Xu C; Han R
    Environ Toxicol Pharmacol; 2015 Nov; 40(3):764-73. PubMed ID: 26433482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.